Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,895 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01234337 | Phase III Trial Comparing Capecitabine in Combination With Sorafenib or Placebo in the Treatment of Locally Advanced or Metastatic HER2-Negative Breast Cancer | completed | Phase 3 | 537 | BayerINDUSTRY | 23 | Nov 6, 2018 | clinicaltrials |
| NCT00089661 | AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Aromatase Inhibitor Therapy for Non-metastatic Breast Cancer | completed | Phase 3 | 252 | AmgenINDUSTRY | 0 | Oct 17, 2018 | clinicaltrials |
| NCT00793962 | A Phase Ⅲ Randomized Clinical Trial of Postmastectomy Hypofractionation Radiotherapy in High-risk Breast Cancer | completed | Phase 3 | 810 | Chinese Academy of Medical SciencesOTHER | 1 | Oct 11, 2018 | clinicaltrials |
| NCT00639106 | Tissue Expander/Implant Reconstruction: A Single-Blinded, Randomized, Controlled Trial | completed | Phase 3 | 70 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 3, 2018 | clinicaltrials |
| NCT00053898 | Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy | completed | Phase 3 | 3,104 | NSABP Foundation IncNETWORK | 3 | Sep 20, 2018 | clinicaltrials |
| NCT01638247 | Tamoxifen +/- GnRH Analogue vs Aromatase Inhibitor + GnRH Analogue in Male Breast Cancer Patients(MALE) | completed | Phase 3 | 56 | GBG Forschungs GmbHOTHER | 1 | Sep 19, 2018 | clinicaltrials |
| NCT02019277 | A Study of Pertuzumab and Trastuzumab Subcutaneous (SC) Treatment in Combination With a Taxane in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer(SAPPHIRE) | completed | Phase 3 | 50 | Hoffmann-La RocheINDUSTRY | 1 | Sep 13, 2018 | clinicaltrials |
| NCT02225470 | Eribulin Versus Vinorelbine in Subjects With Locally Recurrent or Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes | completed | Phase 3 | 530 | Eisai Co., Ltd.INDUSTRY | 1 | Aug 28, 2018 | clinicaltrials |
| NCT01026142 | A Study of a Combination of Trastuzumab and Capecitabine With or Without Pertuzumab in Patients With HER2-positive Metastatic Breast Cancer (PHEREXA) | completed | Phase 3 | 452 | Hoffmann-La RocheINDUSTRY | 23 | Aug 14, 2018 | clinicaltrials |
| NCT01942980 | Evaluation of the Efficacy of Hippocampal Avoidance on the Cognitive Toxicity of Whole-Brain Radiation Therapy After Surgical Resection of Single Brain Metastasis of Breast Cancer | completed | Phase 3 | 8 | Institut Paoli-CalmettesOTHER | 1 | Aug 13, 2018 | clinicaltrials |
| NCT00002942 | Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer | completed | Phase 3 | 136 | Wake Forest University Health SciencesOTHER | 1 | Aug 10, 2018 | clinicaltrials |
| NCT00195013 | Randomized Placebo-Controlled Trial of Glutamine for Breast Cancer Patients With Peripheral Neuropathy | completed | Phase 3 | 30 | Weill Medical College of Cornell UniversityOTHER | 1 | Jun 6, 2018 | clinicaltrials |
| NCT02279108 | Study Assessing The Interest of Indocyanine Green Fluorescence Imaging With Radioisotope Method For Sentinel Lymph Node Biopsy in Patients With Breast Cancer(FLUOTECH) | completed | Phase 3 | 99 | Centre Hospitalier Universitaire de Saint EtienneOTHER | 1 | Apr 9, 2018 | clinicaltrials |
| NCT00689156 | Epirubicin or Not in Patients With TOP2A (Topoisomerase (DNA) II Alpha (170kD)) Normal Early Breast Cancer(READ) | completed | Phase 3 | 2,015 | Danish Breast Cancer Cooperative GroupOTHER | 1 | Apr 5, 2018 | clinicaltrials |
| NCT01668914 | Internal Mammary Sentinel Lymph Node Biopsy in Early Breast Cancer Patients With Clinically Axillary Node -Positive(IMSLNB-CANP) | completed | Phase 3 | 126 | Shandong Cancer Hospital and InstituteOTHER | 1 | Apr 5, 2018 | clinicaltrials |
| NCT00338286 | A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy | completed | Phase 3 | 2,098 | Janssen Research & Development, LLCINDUSTRY | 21 | Mar 19, 2018 | clinicaltrials |
| NCT01792999 | Koning Breast CT for Breast Imaging in China | completed | Phase 3 | 418 | Koning (Tianjin) Medical Equipment Co., LtdINDUSTRY | 1 | Mar 7, 2018 | clinicaltrials |
| NCT01724450 | Carvedilol Effect in Preventing Chemotherapy - Induced Cardiotoxicity(Ceccy) | completed | Phase 3 | 200 | University of Sao PauloOTHER | 1 | Feb 5, 2018 | clinicaltrials |
| NCT00950300 | A Study to Compare Subcutaneous (SC) Versus Intravenous (IV) Administration of Herceptin (Trastuzumab) in Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Early Breast Cancer | completed | Phase 3 | 596 | Hoffmann-La RocheINDUSTRY | 26 | Jan 23, 2018 | clinicaltrials |
| NCT00093795 | Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Positive Breast Cancer | completed | Phase 3 | 4,894 | NSABP Foundation IncNETWORK | 1 | Jan 11, 2018 | clinicaltrials |
| NCT00003830 | Surgery to Remove Sentinel Lymph Nodes With or Without Removing Lymph Nodes in the Armpit in Treating Women With Breast Cancer | completed | Phase 3 | 5,611 | NSABP Foundation IncNETWORK | 3 | Dec 13, 2017 | clinicaltrials |
| NCT00009945 | Clodronate With or Without Chemotherapy and/or Hormonal Therapy in Treating Women With Stage I or Stage II Breast Cancer | completed | Phase 3 | 3,323 | NSABP Foundation IncNETWORK | 1 | Dec 13, 2017 | clinicaltrials |
| NCT00004205 | Letrozole or Tamoxifen in Treating Postmenopausal Women With Breast Cancer(BIG 1-98) | completed | Phase 3 | 8,028 | ETOP IBCSG Partners FoundationNETWORK | 3 | Dec 12, 2017 | clinicaltrials |
| NCT02980965 | Neoadjuvant Chemo-endocrine Therapy Versus Chemotherapy Alone in ER-positive, HER2-negative Breast Cancer | completed | Phase 3 | 249 | Fudan UniversityOTHER | 1 | Nov 13, 2017 | clinicaltrials |
| NCT00382018 | S0500 Treatment Decision Making Based on Blood Levels of Tumor Cells for Metastatic Breast Cancer Treated With Chemo | completed | Phase 3 | 624 | SWOG Cancer Research NetworkNETWORK | 1 | Nov 6, 2017 | clinicaltrials |
| NCT02483767 | Gonadotropin-Releasing Hormone Agonist for the Preservation of Ovarian Function During Chemotherapy in Premenopausal Breast Cancer(POF) | completed | Phase 3 | 98 | Peking Union Medical College HospitalOTHER | 0 | Oct 17, 2017 | clinicaltrials |
| NCT00535418 | Optimal Duration of Pre-operative Treatment With Letrozole and to Correlate Clinical Efficacy With Appropriate Surrogate Markers | completed | Phase 2 / Phase 3 | 35 | Novartis PharmaceuticalsINDUSTRY | 0 | Sep 5, 2017 | clinicaltrials |
| NCT01516736 | Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Peg-Filgrastim(PROTECT2) | completed | Phase 3 | 308 | SandozINDUSTRY | 8 | Aug 30, 2017 | clinicaltrials |
| NCT02001506 | Neoadjuvant Chemotherapy of 6 Cycles vs 8 Cycles in Node Positve Breast Cancer(Neo-shorter) | completed | Phase 3 | 250 | Asan Medical CenterOTHER | 1 | Aug 29, 2017 | clinicaltrials |
| NCT01712893 | Simultaneous Versus Sequential Use of Adjuvant Chemotherapy and GnRHa in Treating ER+,Premenopausal Breast Cancer | completed | Phase 3 | 216 | Fudan UniversityOTHER | 1 | Aug 25, 2017 | clinicaltrials |
| NCT01495650 | Effect of a Tailored Program of Physical Activity and Nutritional Counseling on Fatigue Reduction in Breast Cancer Patients Receiving an Adjuvant Treatment(APAD) | completed | Phase 3 | 240 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Aug 21, 2017 | clinicaltrials |
| NCT00775645 | S0715: Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I, II, or IIIA Breast Cancer Undergoing Chemo | completed | Phase 3 | 437 | SWOG Cancer Research NetworkNETWORK | 1 | Aug 14, 2017 | clinicaltrials |
| NCT01735175 | Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Neulasta®(PROTECT-1) | completed | Phase 3 | 316 | SandozINDUSTRY | 6 | Aug 7, 2017 | clinicaltrials |
| NCT02286778 | Eradication of Malignant Carcinoma in the Breast Tissue | completed | Phase 2 / Phase 3 | 60 | Optimal Health ResearchOTHER | 0 | Aug 3, 2017 | clinicaltrials |
| NCT02125344 | A Phase III Trial Comparing Two Dose-dense, Dose-intensified Approaches (ETC and PM(Cb)) for Neoadjuvant Treatment of Patients With High-risk Early Breast Cancer (GeparOcto) | completed | Phase 3 | 961 | GBG Forschungs GmbHOTHER | 1 | Jul 13, 2017 | clinicaltrials |
| NCT00789581 | A Randomized Trial of Ixempra Versus Taxol in Adjuvant Therapy of Triple Negative Breast Cancer(TITAN) | completed | Phase 3 | 614 | SCRI Development Innovations, LLCOTHER | 2 | Jul 2, 2017 | clinicaltrials |
| NCT00074152 | Adjuvant Chemotherapy in Treating Women Who Have Undergone Resection for Relapsed Breast Cancer; Chemotherapy as Adjuvant for LOcally Recurrent Breast Cancer(CALOR) | completed | Phase 3 | 162 | ETOP IBCSG Partners FoundationNETWORK | 10 | Jun 16, 2017 | clinicaltrials |
| NCT00266799 | The Efficacy and Safety of Pegylated Liposomal Doxorubicin Compared With Capecitabine as First Line Chemotherapy for Metastatic Breast Cancer (P04445/MK-2746-071) | completed | Phase 3 | 210 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Jun 8, 2017 | clinicaltrials |
| NCT01317108 | Prognostic and Predictive Impact of uPA/PAI-1(ChemoN0) | completed | Phase 3 | 689 | Universitätsklinikum Hamburg-EppendorfOTHER | 0 | May 25, 2017 | clinicaltrials |
| NCT01276938 | Exclusive Intraoperative Radiation Therapy for Breast Cancer | completed | Phase 2 / Phase 3 | 40 | IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, ItalyOTHER | 1 | May 24, 2017 | clinicaltrials |
| NCT00041119 | Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer | completed | Phase 3 | 3,871 | Alliance for Clinical Trials in OncologyOTHER | 2 | May 18, 2017 | clinicaltrials |
| NCT00685256 | Standard Genetic Counseling With or Without a Decision Guide in Improving Communication Between Mothers Undergoing BRCA1/2 Testing and Their Minor-Age Children | completed | Phase 3 | 245 | Georgetown UniversityOTHER | 1 | May 17, 2017 | clinicaltrials |
| NCT00092196 | Study of MK0869 for the Prevention of Chemotherapy-Induced Nausea and Vomiting (0869-071)(COMPLETED) | completed | Phase 3 | 820 | Merck Sharp & Dohme LLCINDUSTRY | 0 | May 5, 2017 | clinicaltrials |
| NCT00863655 | Everolimus in Combination With Exemestane in the Treatment of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Who Are Refractory to Letrozole or Anastrozole(BOLERO-2) | completed | Phase 3 | 724 | Novartis PharmaceuticalsINDUSTRY | 24 | May 2, 2017 | clinicaltrials |
| NCT00561119 | Maintenance Versus Observation After 6 Cycles of Gemcitabine Plus Paclitaxel in Pts With Advanced Breast Cancer | completed | Phase 3 | 326 | Samsung Medical CenterOTHER | 1 | May 1, 2017 | clinicaltrials |
| NCT00876486 | Evaluate the Efficacy and Safety of Genexol®-PM Compared to Genexol® in Recurrent or Metastatic Breast Cancer | completed | Phase 3 | 213 | Samyang Biopharmaceuticals CorporationINDUSTRY | 1 | May 1, 2017 | clinicaltrials |
| NCT00045032 | Herceptin (Trastuzumab) in Treating Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Primary Breast Cancer(HERA) | completed | Phase 3 | 5,099 | Hoffmann-La RocheINDUSTRY | 33 | Apr 27, 2017 | clinicaltrials |
| NCT00509444 | Cancer Prevention and Treatment Among African American Older Adults: Treatment Trial(CPTD) | completed | Phase 3 | 200 | Johns Hopkins Bloomberg School of Public HealthOTHER | 1 | Apr 20, 2017 | clinicaltrials |
| NCT01539317 | Therapy to Prevent Sexual Pain in Breast Cancer Survivors | completed | Phase 3 | 50 | OHSU Knight Cancer InstituteOTHER | 1 | Apr 14, 2017 | clinicaltrials |
Data updated 23 days agoSource updated Nov 6, 2018source: clinicaltrials